BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37438905)

  • 1. Research Progress on Small-molecule Inhibitors of Protein Arginine Methyltransferase 5 (PRMT5) for Treating Cancer.
    Guo C; Wu L; Zheng X; Zhao L; Hou X; Wang Z; Han C
    Curr Top Med Chem; 2023; 23(21):2048-2074. PubMed ID: 37438905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicinal chemistry strategies targeting PRMT5 for cancer therapy.
    Fu S; Zheng Q; Zhang D; Lin C; Ouyang L; Zhang J; Chen L
    Eur J Med Chem; 2022 Dec; 244():114842. PubMed ID: 36274274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleoside protein arginine methyltransferase 5 (PRMT5) inhibitors.
    Lin H; Luengo JI
    Bioorg Med Chem Lett; 2019 Jun; 29(11):1264-1269. PubMed ID: 30956011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A patent review of PRMT5 inhibitors to treat cancer (2018 - present).
    Gao J; Yang J; Xue S; Ding H; Lin H; Luo C
    Expert Opin Ther Pat; 2023 Apr; 33(4):265-292. PubMed ID: 37072380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an AlphaLISA high throughput technique to screen for small molecule inhibitors targeting protein arginine methyltransferases.
    Prabhu L; Chen L; Wei H; Demir Ö; Safa A; Zeng L; Amaro RE; O'Neil BH; Zhang ZY; Lu T
    Mol Biosyst; 2017 Nov; 13(12):2509-2520. PubMed ID: 29099132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting protein arginine methyltransferase 5 in cancers: Roles, inhibitors and mechanisms.
    Chen Y; Shao X; Zhao X; Ji Y; Liu X; Li P; Zhang M; Wang Q
    Biomed Pharmacother; 2021 Dec; 144():112252. PubMed ID: 34619493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein arginine methyltransferase 5: a potential cancer therapeutic target.
    Yuan Y; Nie H
    Cell Oncol (Dordr); 2021 Feb; 44(1):33-44. PubMed ID: 33469838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein Arginine Methyltransferase 5 (PRMT5) as an Anticancer Target and Its Inhibitor Discovery.
    Wang Y; Hu W; Yuan Y
    J Med Chem; 2018 Nov; 61(21):9429-9441. PubMed ID: 29870258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flavokawain A is a natural inhibitor of PRMT5 in bladder cancer.
    Liu S; Liu Z; Piao C; Zhang Z; Kong C; Yin L; Liu X
    J Exp Clin Cancer Res; 2022 Oct; 41(1):293. PubMed ID: 36199122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational Design, synthesis and biological evaluation of novel triazole derivatives as potent and selective PRMT5 inhibitors with antitumor activity.
    Zhu K; Shao J; Tao H; Yan X; Luo C; Zhang H; Duan W
    J Comput Aided Mol Des; 2019 Aug; 33(8):775-785. PubMed ID: 31312965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic control via allosteric regulation of mammalian protein arginine methyltransferases.
    Jain K; Jin CY; Clarke SG
    Proc Natl Acad Sci U S A; 2017 Sep; 114(38):10101-10106. PubMed ID: 28874563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of new potent protein arginine methyltransferase 5 (PRMT5) inhibitors by assembly of key pharmacophores from known inhibitors.
    Zhu K; Song JL; Tao HR; Cheng ZQ; Jiang CS; Zhang H
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3693-3699. PubMed ID: 30366617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of PRMT5 inhibitors with novel scaffold structures through virtual screening and biological evaluations.
    Zhang Q; Zhang L; Jin J; Fan Y; Wang X; Hu H; Ye X; Wang L; Cao C; Ye F
    J Mol Model; 2022 Jun; 28(7):184. PubMed ID: 35680707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond.
    Stopa N; Krebs JE; Shechter D
    Cell Mol Life Sci; 2015 Jun; 72(11):2041-59. PubMed ID: 25662273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Structure and Function of the PRMT5:MEP50 Complex.
    Antonysamy S
    Subcell Biochem; 2017; 83():185-194. PubMed ID: 28271477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel small-molecule antagonizes PRMT5-mediated KLF4 methylation for targeted therapy.
    Zhou Z; Feng Z; Hu D; Yang P; Gur M; Bahar I; Cristofanilli M; Gradishar WJ; Xie XQ; Wan Y
    EBioMedicine; 2019 Jun; 44():98-111. PubMed ID: 31101597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein Arginine Methyltransferase 5 (PRMT5) Mutations in Cancer Cells.
    Rasheed S; Bouley RA; Yoder RJ; Petreaca RC
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting protein arginine methyltransferase 5 in disease.
    Richters A
    Future Med Chem; 2017 Nov; 9(17):2081-2098. PubMed ID: 29076773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel selective small-molecule inhibitor of protein arginine methyltransferase 5 (PRMT5) by virtual screening, resynthesis and biological evaluations.
    Zhu K; Jiang C; Tao H; Liu J; Zhang H; Luo C
    Bioorg Med Chem Lett; 2018 May; 28(9):1476-1483. PubMed ID: 29628326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and optimization of selective inhibitors of protein arginine methyltransferase 5 by docking-based virtual screening.
    Ye Y; Zhang B; Mao R; Zhang C; Wang Y; Xing J; Liu YC; Luo X; Ding H; Yang Y; Zhou B; Jiang H; Chen K; Luo C; Zheng M
    Org Biomol Chem; 2017 May; 15(17):3648-3661. PubMed ID: 28397890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.